Alpha Calcitonin Gene-Related Peptide Increases Cerebral Vessel Diameter in Animal Models of Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis

Effect of Endothelin Receptor Antagonists on Clinically Relevant Outcomes after Experimental Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis

(2015) Kamil G Laban et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Tat peptide-decorated gelatin-siloxane nanoparticles for delivery of CGRP transgene in treatment of cerebral vasospasm

(2013) Tian et al.   International Journal of Nanomedicine

Meta-analysis of data from animal studies: A practical guide

(2013) H.M. Vesterinen et al.   JOURNAL OF NEUROSCIENCE METHODS

Role of calcitonin gene-related peptide in cerebral vasospasm, and as a therapeutic approach to subarachnoid hemorrhage

(2012) Stelios Kokkoris et al.   Frontiers in Endocrinology

Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis

(2011) Nima Etminan et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

(2011) R Loch Macdonald et al.   LANCET NEUROLOGY

Critical Care Guidelines on the Endovascular Management of Cerebral Vasospasm

(2011) Matthew M. Kimball et al.   Neurocritical Care

Experimental models of subarachnoid hemorrhage for studies of cerebral vasospasm

(2008) Elena Titova et al.   NEUROLOGICAL RESEARCH

Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1)

(2008) R. Loch Macdonald et al.   STROKE